Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

SONAR Committees and Investigators

    Research output: Contribution to journalArticlepeer-review

    152 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial'. Together they form a unique fingerprint.

    Medicine & Life Sciences